Compare · head to head
Hisamitsu Pharmaceutical vs PharmGen Science
PharmGen Science ranks higher overall — 360 rank 74 vs 61.
PharmGen Science leads on Safety (73 vs 68). The two are close on Quality and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Large | Small |
| ISIN | JP3784600003 | KR7004720009 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 61 | 74 |
| Value | NR | 57 |
| Quality | 58 | 54 |
| Growth | 48 | NR |
| Safety | 68 | 73 |
| Sentiment | 37 | 41 |
| Quality details | ||
| Profitability | 68 | 70 |
| Cash Truth | 48 | 38 |
Hisamitsu Pharmaceutical vs Kukje PharmaHisamitsu Pharmaceutical vs Chong Kun DangHisamitsu Pharmaceutical vs GC BiopharmaHisamitsu Pharmaceutical vs Dongwha PharmAdd a third stock →
Full analyses: Hisamitsu Pharmaceutical · PharmGen Science
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100